Company Filing History:
Years Active: 2013-2015
Title: Ruth Mackay: Innovator in Pharmaceutical Combinations
Introduction
Ruth Mackay is a prominent inventor based in Dundee, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative combinations for treating proliferative disorders. With a total of 2 patents, her work is paving the way for new therapeutic approaches.
Latest Patents
Ruth Mackay's latest patents focus on combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaine. The first aspect of her invention relates to a combination comprising a DNA methyltransferase inhibitor and 1-(2-C-cyano-2-dioxy-β-D-arabino-pentofuranosyl)-N4-palmitoyl cytosine, or a metabolite thereof. The second aspect involves a pharmaceutical product that includes a DNA methyltransferase inhibitor and the aforementioned compound, designed for simultaneous, sequential, or separate use in therapy. The third aspect outlines a method for treating a proliferative disorder, which includes administering both a DNA methyltransferase inhibitor and the specified compound to a subject.
Career Highlights
Ruth Mackay is associated with Cyclacel Limited, where she continues to advance her research and development efforts. Her work is instrumental in exploring new therapeutic avenues that could significantly impact patient care.
Collaborations
Ruth collaborates with notable colleagues, including Simon Richard Green and Ian Fleming, who contribute to her innovative projects and research initiatives.
Conclusion
Ruth Mackay's contributions to the field of pharmaceuticals through her innovative patents and collaborations highlight her role as a key inventor in the industry. Her work continues to inspire advancements in treatment methodologies.